Navigation Links
Genoptix Announces Participation at the Barclays Capital 2010 Global Healthcare Conference
Date:3/15/2010

CARLSBAD, Calif., March 15 /PRNewswire-FirstCall/ -- Genoptix, Inc. ( GXDX), a specialized laboratory services provider, today announced the Company's participation at the Barclays Capital 2010 Global Healthcare Conference at the Loews Miami Hotel in Miami, Fla. to be held March 23-24, 2010.  

Doug Schuling, EVP and CFO of Genoptix, will present at the conference on Tuesday, March 23, 2010 beginning at approximately 2:30 p.m. EDT, when he will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 25 minutes and will be web cast live through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix is a member of the Nasdaq Select Global Market and the S&P SmallCap 600 Index and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.

SOURCE Genoptix, Inc.

Back to top

RELATED LINKS
http://www.genoptix.com

'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009
2. Genoptix, Inc. to Announce Second Quarter 2009 Financial Results
3. Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
4. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
5. Genoptix Reports Strong Growth for the First Quarter of 2009
6. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
7. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
8. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
9. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
10. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
11. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... introducing the Aerolib Learning Management System: an On-demand E-learning system for Clinical ... and Hospital Administration that is based on Aerolib`s successful education methodology of ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... SF expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, ... growing demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... 2017 , ... This month, the CEO and Clinical Director of Sober Living ... center in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO ... Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed ...
(Date:1/19/2017)... ... 19, 2017 , ... WhoHaha , a digital media company dedicated to ... (AHA) to produce a three-part video series that uses humor to highlight ways to ... launch of AHA’s Healthy For Good™ movement, which is designed to inspire all Americans ...
(Date:1/19/2017)... ... 2017 , ... Cosmetic Town, an online plastic surgery community, begins 2017 with ... easier for their readers to get the information they desire. The procedures are now ... techniques used on those particular areas. , “We are excited to streamline our listings ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , , Marks E-QURE , ... agreement, following similar agreements in Israel and ... 5 billion global market ... leader in medical devices for the treatment of advanced wound care, announced today ... in Colombia for the Company,s patented Bio-electrical Signal Therapy ...
(Date:1/19/2017)... Jan. 18, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: